COVAXIN Demonstrates Interim Clinical Efficacy Of 81%
Hyderabad: Bharat Biotech, a global leader in vaccine innovation, developing vaccines for infectious diseases, today announced the first interim analysis of its BBV152 (COVAXIN®). The whole virion inactivated COVID-19 vaccine candidate…